Today: 1 June 2026
Alphabet Shares Dip as Google Stock Faces Another AI Hurdle
1 June 2026
2 mins read

Alphabet Shares Dip as Google Stock Faces Another AI Hurdle

New York, June 1, 2026, 14:18 EDT

Alphabet shares slipped roughly 1.1% as of Monday afternoon, underperforming the QQQ ETF, which was up 0.9%. GOOGL, Alphabet’s Class A stock, last traded at $376.26. Class C shares, GOOG, saw a similar drop.

Alphabet is now viewed as a clear gauge of the market’s AI bet. Investors want to see if artificial intelligence—tools that create or read text, images, or code—can keep powering Google Search and Google Cloud at a strong enough pace to cover the company’s rising spending on infrastructure.

Piper Sandler’s Thomas Champion lifted his price target on Alphabet to $445 from $425 on Monday, keeping his Overweight call on the stock. Overweight says Champion expects the shares to outperform. He pointed to Google as the “clear beneficiary” from AI Search growth after looking at citation data in Google AI Overview and AI Mode, according to TipRanks. TipRanks

Truist kept a positive view too. Analyst Youssef Squali bumped his Alphabet target to $430 from $415, according to Investing.com. He said the consensus estimate for Google Cloud revenue was “below what they should be” and pointed to backlog and recent wins. Investing.com

Bullish investors point to Alphabet’s April report, where first-quarter revenue climbed 22% to $109.9 billion. Google Cloud was up 63% at $20.0 billion. CEO Sundar Pichai said AI investments are “lighting up every part of the business.” The company also said Cloud backlog was almost twice what it was last quarter, now above $460 billion.

Still, the bill is big. After Alphabet’s earnings, Reuters said CFO Anat Ashkenazi put the company’s 2026 capex outlook at $180 billion to $190 billion. That’s spending on things like servers and data centers. Google has also started selling its own AI chips, called Tensor Processing Units, or TPUs. That move puts Google in the AI chip race with Nvidia, even as its cloud business still runs on Nvidia GPUs.

Nvidia climbed 6.2% and Microsoft added 2.2%. Amazon dropped 3.1%. Alphabet shares stuck near the cloud spend story, not the chip gains.

Regulation is in focus again after Reuters said Monday that new draft EU cloud rules could put tough criteria on key state contracts, possibly barring Amazon, Microsoft and Google from certain deals. The draft is tied to the Cloud and AI Development Act, part of a move by the EU to cut back on U.S. tech suppliers.

DuckDuckGo is seeing a spike in users on its “no-AI” search. TechCrunch said traffic to that search page jumped three times on May 28 and has stayed up, averaging 84% over normal since Google’s AI-search changes. DuckDuckGo responded by making the “no-AI” version easier to find. TechCrunch

But there’s a clear downside. Stricter EU procurement rules might close off certain cloud deals, less interest in AI search answers could dent engagement, and planned capex of nearly $190 billion would hit cash flow if growth tapers. Monday’s buyers still saw that risk.

Investors are looking at two dates. EU tech chief Henna Virkkunen plans to announce the cloud package Wednesday. Alphabet’s annual meeting is on Friday at 9 a.m. Pacific.

Wall Street upgrades didn’t stop Alphabet from missing out on the wider tech rally. The stock is still part of the AI story, but Monday’s trading showed it’s also exposed to the costs of that push.

Stock Market Today

  • AI Leader Anthropic Confidentially Files for $47B Revenue IPO Amid Intense AI Sector Expansion
    June 1, 2026, 2:30 PM EDT. Anthropic, renowned for its Claude AI chatbot, confidentially filed for its IPO with the SEC, aiming to capitalize on soaring demand in AI services. Founded in 2021 by ex-OpenAI executives Dario and Daniela Amodei, the company recently raised $6.5 billion, valuing it at $96.5 billion, surpassing OpenAI's March valuation of $85.2 billion. Anthropic's focus on AI safety and enterprise offerings helps drive projected revenue of $47 billion annually. The filing awaits SEC review, with share price and volume undecided, and will depend on market conditions. Addressing computing power challenges, Anthropic secured multi-gigawatt deals with Amazon, Google, and Broadcom, and notably agreed with Elon Musk to lease Colossus data centers for $1.25 billion monthly. This move positions Anthropic alongside OpenAI and Musk's SpaceX in upcoming Wall Street tech listings.

Latest articles

Alphabet Shares Dip as Google Stock Faces Another AI Hurdle

Alphabet Shares Dip as Google Stock Faces Another AI Hurdle

1 June 2026
New York, June 1, 2026, 14:18 EDT Alphabet shares slipped roughly 1.1% as of Monday afternoon, underperforming the QQQ ETF, which was up 0.9%. GOOGL, Alphabet’s Class A stock, last traded at $376.26. Class C shares, GOOG, saw a similar drop. Alphabet is now viewed as a clear gauge of the market’s AI bet. Investors want to see if artificial intelligence—tools that create or read text, images, or code—can keep powering Google Search and Google Cloud at a strong enough pace to cover the company’s rising spending on infrastructure. Piper Sandler’s Thomas Champion lifted his price target on Alphabet to
Nvidia Stock Gains as RTX AI PC Chip Raises Stakes for Intel, AMD

Nvidia Stock Gains as RTX AI PC Chip Raises Stakes for Intel, AMD

1 June 2026
Nvidia surged 6.2% to $224.27 after unveiling RTX Spark, an AI chip for Windows PCs, intensifying competition with Intel, AMD, and Qualcomm. Market cap hit $5.47 trillion. Intel slid 3.7%, Qualcomm 7.3%, AMD 0.5%. RTX Spark, built with MediaTek, launches this fall in major brands. Key risks: weak AI PC demand and China export caps still cloud Nvidia’s outlook.
Why AIM ImmunoTech Stock More Than Doubled Today After a Pancreatic Cancer Trial Surprise

Why AIM ImmunoTech Stock More Than Doubled Today After a Pancreatic Cancer Trial Surprise

1 June 2026
AIM ImmunoTech shares soared over 100% to 92.79 cents on record volume after its pancreatic-cancer trial hit final subject enrollment ahead of schedule. The last patient is set for mid-June treatment, with the main Ampligen efficacy readout due in December. AIM recently raised $2.4 million in a discounted share offering, adding dilution risk. Monday’s rally came as biotech peers fell, highlighting stock-specific momentum.
Nvidia Stock Gains as RTX AI PC Chip Raises Stakes for Intel, AMD
Previous Story

Nvidia Stock Gains as RTX AI PC Chip Raises Stakes for Intel, AMD

Go toTop